A5009904276- Treatment of Major Depression
- Tryptophan and brain disorders
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
- Health, psychology, and well-being
- COVID-19 and Mental Health
- Stress Responses and Cortisol
- Health disparities and outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Neurotransmitter Receptor Influence on Behavior
- Mental Health Research Topics
- Sleep and related disorders
- Mental Health Treatment and Access
- Schizophrenia research and treatment
- Cancer-related cognitive impairment studies
- Impact of Technology on Adolescents
- Delphi Technique in Research
- Child Nutrition and Feeding Issues
- Long-Term Effects of COVID-19
- Infant Health and Development
- Gastrointestinal motility and disorders
- Psychological and Temporal Perspectives Research
- Aging and Gerontology Research
- Receptor Mechanisms and Signaling
- Child and Adolescent Psychosocial and Emotional Development
University Health Network
2019-2025
McMaster University
2025
Health Net
2021
University of Toronto
2019-2020
Toronto Western Hospital
2020
Cambridge University Press
2019
Engineering Associates (United States)
2019
Abstract Background Improving functioning in adults with major depressive disorder (MDD) and bipolar (BD) is a priority therapeutic objective. Methods This retrospective post hoc secondary analysis evaluated 108 patients MDD or BD receiving the antidepressants vortioxetine, ketamine, infliximab. The aimed to determine if changes objective subjective cognitive function mediated relationship between depression symptom severity workplace outcomes. Cognitive was measured by Perceived Deficits...
Benzodiazepine (BZD) prescription rates have increased over the past decade in United States. Available literature indicates that sociodemographic factors may influence diagnostic patterns and/or behaviour. Herein, aim of this study is to determine whether gender prescriber patient influences BZD prescription.Cross-sectional using data from Florida Medicaid Managed Medical Assistance Program January 1, 2018 December 31, 2018. Eligible recipients ages 18 64, inclusive, enrolled plan for at...